| scholarly article | Q13442814 |
| P50 | author | Thomas J Jackson | Q59784596 |
| P2093 | author name string | Martin Bushell | |
| David Ferland-McCollough | |||
| Yi W Kong | |||
| P2860 | cites work | MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia | Q21092263 |
| Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1 | Q21092854 | ||
| The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis | Q24293460 | ||
| MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators | Q24336898 | ||
| miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
| Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
| miRNA and vascular cell movement | Q24598174 | ||
| Repression of versican expression by microRNA-143 | Q24607134 | ||
| The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes | Q24628676 | ||
| MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis | Q24634064 | ||
| Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation | Q24645026 | ||
| MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype | Q24646090 | ||
| miR-19 is a key oncogenic component of mir-17-92 | Q24652326 | ||
| MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma | Q24653676 | ||
| A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk | Q24655762 | ||
| Circulating microRNAs, potential biomarkers for drug-induced liver injury | Q24656209 | ||
| A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma | Q27851611 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
| The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 | ||
| Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 | ||
| The role of let-7 in cell differentiation and cancer | Q28259549 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia | Q28279141 | ||
| Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells | Q28283249 | ||
| p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication | Q28587920 | ||
| Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis | Q29547575 | ||
| Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma | Q29547772 | ||
| Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma | Q29614238 | ||
| Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
| miR-21-mediated tumor growth | Q29616149 | ||
| The microRNA spectrum in 12 body fluids | Q29618068 | ||
| Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells | Q29619847 | ||
| microRNAs as oncogenes and tumor suppressors | Q29619907 | ||
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis | Q30004190 | ||
| Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer | Q31022382 | ||
| Detection of tumor marker CA125 in ovarian carcinoma using quantum dots | Q31120718 | ||
| Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis | Q33397113 | ||
| Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues | Q33693132 | ||
| Selective release of microRNA species from normal and malignant mammary epithelial cells | Q33728084 | ||
| A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer | Q33742015 | ||
| Fecal MicroRNAs as novel biomarkers for colon cancer screening | Q33981746 | ||
| Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study | Q34020155 | ||
| MicroRNAs associated with metastatic prostate cancer | Q34042888 | ||
| OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. | Q34130311 | ||
| LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. | Q34359833 | ||
| MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration | Q34426103 | ||
| Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. | Q34783833 | ||
| Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. | Q34959865 | ||
| A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer | Q34976475 | ||
| Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications | Q35086100 | ||
| Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice | Q35086711 | ||
| Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice | Q35673271 | ||
| Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth | Q35846712 | ||
| Nanoparticle and targeted systems for cancer therapy | Q35879221 | ||
| mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer | Q36103305 | ||
| MicroRNA-cancer connection: the beginning of a new tale | Q36555283 | ||
| MicroRNA expression profiling in cancer from a bioinformatics prospective | Q37004629 | ||
| The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies | Q37326072 | ||
| Karyotype-specific microRNA signature in chronic lymphocytic leukemia | Q37412319 | ||
| Gene-expression-based prognostic assays for breast cancer | Q37741797 | ||
| Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways | Q37820099 | ||
| Cancer stem cells and cancer therapy | Q37841186 | ||
| MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth | Q38298486 | ||
| Circulating microRNAs as novel minimally invasive biomarkers for breast cancer | Q39281588 | ||
| Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy | Q39464045 | ||
| Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells | Q39601112 | ||
| Fluorescent nanocrystals for use in early cervical cancer detection | Q40378537 | ||
| Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots | Q42807706 | ||
| Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer | Q43539336 | ||
| MiR-30 family and EMT in human fetal pancreatic islets | Q43565364 | ||
| MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology | Q44613300 | ||
| Unlocked nucleic acid (UNA) and UNA derivatives: thermal denaturation studies | Q46384202 | ||
| Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. | Q48054446 | ||
| Cytomorphologic differentiation of benign and malignant mammary tumors in fine needle aspirate specimens from irradiated female Sprague-Dawley rats. | Q51699567 | ||
| Epithelial-mesenchymal transition and the invasive potential of tumors. | Q51959766 | ||
| MicroRNA profiling differentiates colorectal cancer according to KRAS status. | Q54348636 | ||
| Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. | Q54390446 | ||
| Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study | Q57192409 | ||
| Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of α-Tocopherol | Q95780509 | ||
| P433 | issue | 6 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | e249-58 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Lancet Oncology Commission | Q13747613 |
| P1476 | title | microRNAs in cancer management | |
| P478 | volume | 13 |
| Q41242139 | A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1. |
| Q36251395 | A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients |
| Q92307715 | A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma |
| Q50421175 | A Semi-Supervised Learning Algorithm for Predicting Four Types MiRNA-Disease Associations by Mutual Information in a Heterogeneous Network. |
| Q51315251 | A genetic variant in the seed region of miR-4513 shows pleiotropic effects on lipid and glucose homeostasis, blood pressure, and coronary artery disease. |
| Q34323652 | A mouse strain defective in both T cells and NK cells has enhanced sensitivity to tumor induction by plasmid DNA expressing both activated H-Ras and c-Myc |
| Q37609497 | A novel serum microRNA signature to screen esophageal squamous cell carcinoma |
| Q33798418 | A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma |
| Q46875493 | A universal design for a DNA probe providing ratiometric fluorescence detection by generation of silver nanoclusters |
| Q36104826 | AKI Recovery Induced by Mesenchymal Stromal Cell-Derived Extracellular Vesicles Carrying MicroRNAs |
| Q85654277 | Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients |
| Q35973626 | Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release |
| Q37420793 | Advances in miRNA-Mediated Mucin Regulation. |
| Q38491448 | Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China |
| Q51736279 | Amiodarone promotes cancer cell death through elevated truncated SRSF3 and downregulation of miR-224. |
| Q42681752 | An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration |
| Q41764807 | An integrated approach of predicted miR-34a targets identifies a signature for gastric cancer |
| Q90613693 | Answer to Controversy: miR-10a Replacement Approaches Do Not Offer Protection against Chemotherapy-Induced Gonadotoxicity in Mouse Model |
| Q38781057 | Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel |
| Q50048334 | Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China. |
| Q64083358 | Association between TP53 genetic polymorphisms and the methylation and expression of miR-34a, 34b/c in colorectal cancer tissues |
| Q33594041 | Association between two common polymorphisms and risk of hepatocellular carcinoma: evidence from an updated meta-analysis |
| Q33913814 | Association of miR-608 rs4919510 polymorphism and cancer risk: a meta-analysis based on 13,664 subjects |
| Q92581360 | Associations of Circulating MicroRNAs (miR-17, miR-21, and miR-150) and Chronic Kidney Disease in a Japanese Population |
| Q37328505 | Associations of Il-1 Family-Related Polymorphisms With Gastric Cancer Risk and the Role of Mir-197 In Il-1f5 Expression |
| Q35632022 | Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC. |
| Q37209989 | Bioinformatics and Microarray Analysis of miRNAs in Aged Female Mice Model Implied New Molecular Mechanisms for Impaired Fracture Healing. |
| Q52665030 | Bioinformatics prioritization of SNPs perturbing microRNA regulation of hematological malignancy-implicated genes. |
| Q46847129 | Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis. |
| Q35854540 | Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles Includes "microRNA-like" tRNA Fragments |
| Q98195510 | C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the miR-29b/Akt pathway |
| Q91840494 | CREB1-induced miR-1204 promoted malignant phenotype of glioblastoma through targeting NR3C2 |
| Q47438222 | CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2. |
| Q37074275 | Candidate genes of Waldenström's macroglobulinemia: current evidence and research. |
| Q90432664 | Carbon-Ion Beam Irradiation Alone or in Combination with Zoledronic acid Effectively Kills Osteosarcoma Cells |
| Q35098328 | Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer. |
| Q37716411 | Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer |
| Q47106247 | Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment. |
| Q58582706 | Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma |
| Q92172431 | Circulating microRNAs (miR-126, miR-197, and miR-223) are associated with chronic kidney disease among elderly survivors of the Great East Japan Earthquake |
| Q97519907 | Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis |
| Q35643888 | Circulating microRNAs Reveal Time Course of Organ Injury in a Porcine Model of Acetaminophen-Induced Acute Liver Failure |
| Q91743634 | Circulating microRNAs and Their Role in Multiple Myeloma |
| Q35925992 | Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer |
| Q38190817 | Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract. |
| Q36320168 | Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer |
| Q34029428 | Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer |
| Q35018941 | Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma |
| Q38214780 | Concise review: MicroRNA function in multipotent mesenchymal stromal cells. |
| Q92346833 | Current role of non-coding RNAs in the clinical setting |
| Q37739791 | Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer |
| Q36427777 | DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer |
| Q34749597 | Deciphering the unique microRNA signature in human esophageal adenocarcinoma |
| Q38988230 | Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis |
| Q96230908 | Deoxycholic acid modulates the progression of gallbladder cancer through N6-methyladenosine-dependent microRNA maturation |
| Q91834787 | Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma |
| Q37080521 | Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. |
| Q99579438 | Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors |
| Q38472308 | Differential expression profiles of microRNAs/mRNA and docking study in oral squamous cell carcinoma |
| Q36772110 | Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer |
| Q37406961 | Discovery of genes from feces correlated with colorectal cancer progression |
| Q38905792 | Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma. |
| Q38975536 | Diverse roles of miR-335 in development and progression of cancers |
| Q45823276 | Down-regulation of microRNA-29c is associated with renal failure in multiple myeloma |
| Q58799732 | Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer |
| Q35716165 | Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma |
| Q38874857 | Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer |
| Q42181105 | Drosophila exoribonuclease nibbler is a tumor suppressor, acts within the RNAi machinery and is not enriched in the nuage during early oogenesis |
| Q52655296 | Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis. |
| Q37252292 | Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer |
| Q41127797 | Dysregulation of the miR-194-CUL4B negative feedback loop drives tumorigenesis in non-small-cell lung carcinoma. |
| Q92771325 | Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma |
| Q28542491 | Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells |
| Q58761772 | Effect of dietary components on miRNA and colorectal carcinogenesis |
| Q90481060 | Effect of miR-205 on proliferation and migration of thyroid cancer cells by targeting CCNB2 and the mechanism |
| Q34389137 | Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma |
| Q38314583 | Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221. |
| Q46045622 | Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases |
| Q26865904 | Emerging therapeutic biomarkers in endometrial cancer |
| Q64237241 | Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells |
| Q47105498 | Engineered Zn(II)-Dipicolylamine-Gold Nanorod Provides Effective Prostate Cancer Treatment by Combining siRNA Delivery and Photothermal Therapy |
| Q33838411 | Engineering Exosomes for Cancer Therapy. |
| Q35752431 | Enrichment Analysis Identifies Functional MicroRNA-Disease Associations in Humans |
| Q59355318 | Epstein-Barr virus miRNA-BART16 modulates cell proliferation by targeting LMP1 |
| Q35792727 | Expression Profile Analysis of miR-221 and miR-222 in Different Tissues and Head Kidney Cells of Cynoglossus semilaevis, Following Pathogen Infection |
| Q39221459 | Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells |
| Q61799084 | Expression of microRNAs 16, 20a, 150 and 155 in anal squamous intraepithelial lesions from high-risk groups |
| Q57803478 | Expression profiles and prognostic value of miRNAs in retinoblastoma |
| Q37235523 | Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. |
| Q60933541 | Functional microRNA binding site variants |
| Q90672455 | Gastric Cancer MicroRNAs Meta-signature |
| Q42365350 | Genetic polymorphisms of non-coding RNAs associated with increased head and neck cancer susceptibility: a systematic review and meta-analysis |
| Q57174398 | Genomics and Epigenetics of Malignant Mesothelioma |
| Q37683511 | IRS-2 Partially Compensates for the Insulin Signal Defects in IRS-1-/- Mice Mediated by miR-33. |
| Q91012324 | Identification and profiling of microRNAs expressed in oral buccal mucosa squamous cell carcinoma of Chinese hamster |
| Q47151820 | Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer |
| Q36451789 | Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma. |
| Q35060742 | Identification of miR-30e* regulation of Bmi1 expression mediated by tumor-associated macrophages in gastrointestinal cancer |
| Q35151588 | Identification of miRNAs differentially expressed in clinical stages of human colorectal carcinoma-an investigation in Guangzhou, China |
| Q36889636 | Identification of serum microRNA profiles in colon cancer |
| Q37514211 | Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma |
| Q36737701 | Impact of brief exercise on peripheral blood NK cell gene and microRNA expression in young adults |
| Q33274852 | Integrated miRNA-mRNA analysis revealing the potential roles of miRNAs in chordomas |
| Q44398546 | Integrative analysis of BSG expression in NPC through immunohistochemistry and public high-throughput gene expression data |
| Q38197931 | Interaction between gastric cancer stem cells and the tumor microenvironment |
| Q36552755 | Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients |
| Q64084436 | Interplay Between ncRNAs and Cellular Communication: A Proposal for Understanding Cell-Specific Signaling Pathways |
| Q37611360 | Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer |
| Q26744842 | Investigative and extrapolative role of microRNAs' genetic expression in breast carcinoma |
| Q37525801 | KLF4 functions as an activator of the androgen receptor through reciprocal feedback |
| Q37303709 | Label-Free Isothermal Amplification Assay for Specific and Highly Sensitive Colorimetric miRNA Detection |
| Q35177642 | Lack of Association between miRNA-146a rs2910164 and miRNA-499 rs3746444 Gene Polymorphisms and Susceptibility to Pulmonary Tuberculosis |
| Q34989263 | Lack of association between hsa-miR-149 rs2292832 polymorphism and cancer risk: a meta-analysis of 12 studies |
| Q30313819 | Liquid Profiling in Lung Cancer - Quantification of Extracellular miRNAs in Bronchial Lavage |
| Q48124218 | Long Non-Coding RNAs in Multiple Myeloma |
| Q52776853 | Long Noncoding RNA PVT1 Promotes Melanoma Progression Via Endogenous Sponging MiR-26b. |
| Q36154119 | Long non-coding RNA LSINCT5 predicts negative prognosis and exhibits oncogenic activity in gastric cancer |
| Q41143566 | Long non-coding RNAs as novel biomarkers for breast cancer invasion and metastasis |
| Q28070169 | Long non-coding RNAs in normal and malignant hematopoiesis |
| Q38466810 | Long noncoding RNAs: a potential novel class of cancer biomarkers |
| Q49335182 | Lysosome-associated membrane protein 2 (LAMP-2) expression induced by miR-194-5p downregulation contributes to sunitinib resistance in human renal cell carcinoma cells. |
| Q39014798 | MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b |
| Q38288620 | Machine learning-based identification of endogenous cellular microRNA sponges against viral microRNAs |
| Q36709368 | Mechanism of Regulatory Effect of MicroRNA-206 on Connexin 43 in Distant Metastasis of Breast Cancer |
| Q42366647 | Meta-analysis of the association between three microRNA polymorphisms and breast cancer susceptibility |
| Q39024985 | MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway |
| Q37187706 | MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells |
| Q35225191 | MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma |
| Q37447873 | MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6. |
| Q28564217 | MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3 |
| Q37699427 | MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo. |
| Q54977131 | MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4. |
| Q90734186 | MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma |
| Q90304914 | MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2 |
| Q92616988 | MiR-381 functions as a tumor suppressor in gastric cancer by targeting ROCK2 |
| Q28393361 | MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression |
| Q91723896 | MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A |
| Q40948560 | MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma |
| Q34476593 | MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells |
| Q58753107 | MiRNA Dysregulation in Childhood Hematological Cancer |
| Q39103202 | MicroRNA Biomarkers in Neurodegenerative Diseases and Emerging Nano-Sensors Technology. |
| Q34538870 | MicroRNA Methylation in Colorectal Cancer |
| Q53137197 | MicroRNA and cancer. |
| Q90704211 | MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort study |
| Q27026746 | MicroRNA dysregulation in uveal melanoma: a new player enters the game |
| Q33907481 | MicroRNA function in the profibrogenic interplay upon chronic liver disease |
| Q37669025 | MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma |
| Q47135813 | MicroRNA profiling and bioinformatics analyses reveal the potential roles of microRNAs in chordoma |
| Q91594438 | MicroRNA profiling and identification of let-7a as a target to prevent chemotherapy-induced primordial follicles apoptosis in mouse ovaries |
| Q35793894 | MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype |
| Q37744968 | MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma |
| Q54191926 | MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis. |
| Q47097250 | MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression |
| Q41947674 | MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer. |
| Q43560853 | MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma |
| Q41901440 | MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma |
| Q41145017 | MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma |
| Q52714608 | MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN. |
| Q41612682 | MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer |
| Q35850227 | MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin |
| Q53515189 | MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer. |
| Q91665901 | MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells |
| Q57788850 | MicroRNA-217 functions as a tumor suppressor in cervical cancer cells through targeting Rho-associated protein kinase 1 |
| Q55025344 | MicroRNA-219-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Regulating Cadherin 1. |
| Q91620778 | MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway |
| Q38562796 | MicroRNA-224: as a potential target for miR-based therapy of cancer |
| Q37671418 | MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma |
| Q40714376 | MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer |
| Q47804377 | MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling. |
| Q64230142 | MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1 |
| Q37089955 | MicroRNA-376a sensitizes cells following DNA damage by downregulating MEPE expression |
| Q53033550 | MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma. |
| Q89984623 | MicroRNA-4316 inhibits gastric cancer proliferation and migration via directly targeting VEGF-A |
| Q93195909 | MicroRNA-4476 promotes glioma progression through a miR-4476/APC/β-catenin/c-Jun positive feedback loop |
| Q49211101 | MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer. |
| Q64119982 | MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2 |
| Q64898674 | MicroRNA-550a is associated with muscle system conferring poorer survival for esophageal cancer. |
| Q55022191 | MicroRNA-708-3p as a potential therapeutic target via the ADAM17-GATA/STAT3 axis in idiopathic pulmonary fibrosis. |
| Q90353755 | MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression |
| Q36131780 | MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis |
| Q26780358 | MicroRNAS in endometrial cancer: recent advances and potential clinical applications |
| Q35602071 | MicroRNAs Induce Epigenetic Reprogramming and Suppress Malignant Phenotypes of Human Colon Cancer Cells |
| Q38197247 | MicroRNAs and their relevance to ABC transporters. |
| Q38176833 | MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a. |
| Q35271157 | MicroRNAs as potential biomarkers in cancer: opportunities and challenges |
| Q38795034 | MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases. |
| Q38165818 | MicroRNAs delivered by extracellular vesicles: an emerging resistance mechanism for breast cancer. |
| Q53456657 | MicroRNAs expression in normal and malignant colon tissues as biomarkers of colorectal cancer and in response to pomegranate extracts consumption: Critical issues to discern between modulatory effects and potential artefacts. |
| Q38097415 | MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review |
| Q28085250 | MicroRNAs in the pathobiology of sarcomas |
| Q38111235 | MicroRNAs mark in the MLL-rearranged leukemia |
| Q26765477 | MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment |
| Q34326553 | MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential |
| Q27028132 | Microbiota impact on the epigenetic regulation of colorectal cancer |
| Q36502779 | Molecular biology of gynecological cancer |
| Q26778376 | Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH |
| Q45893062 | Nanomaterials-Based Fluorimetric Methods for MicroRNAs Detection. |
| Q37363891 | Network Consistency Projection for Human miRNA-Disease Associations Inference |
| Q36324801 | Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma |
| Q38885495 | Noncoding RNAs in Therapeutic Resistance of Cancer |
| Q27011225 | Noncoding RNAs in cancer and cancer stem cells |
| Q41612520 | Overexpression of long noncoding RNA PEG10 promotes proliferation, invasion and metastasis of hypopharyngeal squamous cell carcinoma |
| Q36682155 | Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3. |
| Q36468610 | Overview of micro- and nano-technology tools for stem cell applications: micropatterned and microelectronic devices |
| Q89823493 | PVT1 Long Non-coding RNA in Gastrointestinal Cancer |
| Q38093422 | Personalised treatment of haematological malignancies through systems medicine based on single molecules in single cells |
| Q60301008 | Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients |
| Q38125132 | Polycomb group proteins and MYC: the cancer connection. |
| Q53228616 | Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients. |
| Q39070721 | Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets |
| Q49679337 | Pre-micro RNA-499 Gene Polymorphism rs3746444 T/C is Associated with Susceptibility to Rheumatoid Arthritis in Egyptian Population. |
| Q64264889 | Predicting MicroRNA Target Genes and Identifying Hub Genes in IIA Stage Colon Cancer Patients Using Bioinformatics Analysis |
| Q37681002 | Predictive Value of MiR-219-1, MiR-938, MiR-34b/c, and MiR-218 Polymorphisms for Gastric Cancer Susceptibility and Prognosis |
| Q36464885 | Predictive role of miR-146a rs2910164 (C>G), miR-149 rs2292832 (T>C), miR-196a2 rs11614913 (T>C) and miR-499 rs3746444 (T>C) in the development of hepatocellular carcinoma |
| Q57116698 | Prognostic Role of MicroRNA-497 In Cancer Patients: A Meta-analysis |
| Q30235175 | Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis |
| Q45056241 | Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma |
| Q43847258 | Prognostic evaluation of microRNA-210 in various carcinomas: Evidence from 19 studies |
| Q39788725 | Prognostic impact of a 3-MicroRNA signature in cytological samples of small cell lung cancer |
| Q33275146 | Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma |
| Q44140172 | Prognostic significance of serum miR-17-5p in lung cancer |
| Q93018335 | Prognostic value of miR-221 in human malignancy: evidence from 3041 subjects |
| Q37584292 | Prospects of miRNA-based therapy for pancreatic cancer |
| Q45746024 | Quantitative assessment of the association between microRNA-499 rs3746444 A/G polymorphism and cancer risk |
| Q38975876 | RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224. |
| Q34776553 | Real-time monitoring of miRNA function in pancreatic cell lines using recombinant AAV-based miRNA Asensors |
| Q38790306 | Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer |
| Q33599015 | Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer |
| Q36963728 | Regulation of lung cancer metastasis by Klf4-Numb-like signaling |
| Q90634169 | Regulation of the small GTPase Ran by miR-802 modulates proliferation and metastasis in colorectal cancer cells |
| Q35113163 | Retracted: MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer |
| Q39165476 | Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer. |
| Q34993924 | Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review) |
| Q33559304 | Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. |
| Q38216239 | Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy. |
| Q41672604 | Roles of miR-138 and ISG15 in oral squamous cell carcinoma |
| Q35619400 | STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells |
| Q40251268 | Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer. |
| Q34004659 | Serum miRNA signature in Moyamoya disease |
| Q35087659 | Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes |
| Q37133785 | Signal transduction in the development of pulmonary arterial hypertension |
| Q49670471 | Small RNA sequencing profiles of mir-181 and mir-221, the most relevant microRNAs in acute myeloid leukemia. |
| Q42356986 | Small RNAs have a big effect on polycystic kidney disease |
| Q38972399 | Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2. |
| Q91707587 | Specific miRNA expression profile in the blood serum of cardiac myxoma patients |
| Q38810089 | Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells |
| Q64102820 | Superparamagnetic iron oxide nanoparticle-mediated expression of inhibits human endometrial carcinoma stem cell growth |
| Q37225551 | Systematic evaluation of cancer risk associated with rs2292832 in miR‑149 and rs895819 in miR‑27a: a comprehensive and updated meta‑analysis |
| Q92258573 | Systems and Synthetic microRNA Biology: From Biogenesis to Disease Pathogenesis |
| Q37577414 | TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus |
| Q42777873 | TDP-43 regulates cancer-associated microRNAs. |
| Q55629415 | The Role of Curcumin in Prevention and Management of Metastatic Disease. |
| Q64060035 | The Role of MicroRNAs in Hepatoblastoma Tumors |
| Q37091920 | The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer |
| Q38938079 | The Value of MiR-383, an Intronic MiRNA, as a Diagnostic and Prognostic Biomarker in Intestinal-Type Gastric Cancer |
| Q38891154 | The Value of miR-299-5p in Diagnosis and Prognosis of Intestinal-Type Gastric Adenocarcinoma. |
| Q39126198 | The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. |
| Q38755667 | The anti-oncogenic influence of ellagic acid on colon cancer cells in leptin-enriched microenvironment. |
| Q51310017 | The association of common polymorphisms in miR-196a2 with waist to hip ratio and miR-1908 with serum lipid and glucose. |
| Q45937007 | The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers. |
| Q58754543 | The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients |
| Q38156047 | The emerging role of miR-375 in cancer |
| Q26740283 | The emerging role of miR-506 in cancer |
| Q34310378 | The epigenetics of epithelial-mesenchymal plasticity in cancer |
| Q39353707 | The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies |
| Q33798887 | The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions |
| Q59330317 | The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene |
| Q39202832 | The miR-30 family: Versatile players in breast cancer |
| Q45901790 | The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab. |
| Q51764980 | The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer. |
| Q91792434 | The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma |
| Q26744149 | The role of microRNAs in bladder cancer |
| Q36396579 | The role of microRNAs in breast cancer migration, invasion and metastasis |
| Q64262299 | The rs4919510 G>C polymorphism confers reduce coronary injury of Kawasaki disease in a Southern Chinese population |
| Q38962587 | The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway |
| Q30411597 | The urine microRNA profile may help monitor post-transplant renal graft function |
| Q38310488 | Thinking small: towards microRNA-based therapeutics for anxiety disorders |
| Q34343614 | Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab. |
| Q37212187 | U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis |
| Q39432577 | Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets. |
| Q34667439 | Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma |
| Q90424166 | Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis |
| Q33716038 | Versatile RNA interference nanoplatform for systemic delivery of RNAs. |
| Q35878681 | Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells |
| Q50999969 | [miR-202 contributes to sensitizing MM cells to drug significantly via activing JNK/SAPK signaling pathway]. |
| Q47152865 | hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC. |
| Q89537628 | miR-100 Inhibits Cell Growth and Proliferation by Targeting HOXA1 in Nasopharyngeal Carcinoma |
| Q36132797 | miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma |
| Q37705826 | miR-124 represses the mesenchymal features and suppresses metastasis in Ewing sarcoma |
| Q37535463 | miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2. |
| Q39059633 | miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2. |
| Q41473012 | miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer |
| Q92939658 | miR-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo |
| Q38971368 | miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway |
| Q39062167 | miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin |
| Q38838174 | miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1. |
| Q44055579 | miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17. |
| Q36545884 | miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F |
| Q42322707 | miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo |
| Q36772022 | miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways |
| Q38855018 | miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1. |
| Q37428692 | miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. |
| Q38833391 | miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA. |
| Q34096085 | miR-21 promotes the differentiation of hair follicle-derived neural crest stem cells into Schwann cells |
| Q37582210 | miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer |
| Q38780717 | miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway |
| Q91593318 | miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma |
| Q38093079 | miR-221/222: promising biomarkers for breast cancer |
| Q35023269 | miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells |
| Q88716794 | miR-301a plays a pivotal role in hypoxia-induced gemcitabine resistance in pancreatic cancer |
| Q52655303 | miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein. |
| Q35769117 | miR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development. |
| Q39091716 | miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway |
| Q40985945 | miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients |
| Q38703593 | miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression |
| Q90526172 | miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs |
| Q35167131 | miR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein |
| Q53627455 | miR-644a Inhibits Cellular Proliferation and Invasion via Suppression of CtBP1 in Gastric Cancer Cells. |
| Q38960051 | miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway |
| Q39028436 | miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. |
| Q51763083 | miR199a-5p inhibits hepatic insulin sensitivity via suppression of ATG14-mediated autophagy. |
| Q53508723 | miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor. |
| Q53474022 | miRNA-214 Inhibits Cellular Proliferation and Migration in Glioma Cells Targeting Caspase 1 Involved in Pyroptosis. |
| Q92512023 | miRNA-574-3p inhibits metastasis and chemoresistance of epithelial ovarian cancer (EOC) by negatively regulating epidermal growth factor receptor (EGFR) |
| Q38187448 | miRNAs and their application in drug-induced liver injury |
| Q38365504 | miRNAs in inflammatory skin diseases and their clinical implications. |
| Q42546641 | miRNA‑504 inhibits p53‑dependent vascular smooth muscle cell apoptosis and may prevent aneurysm formation |
| Q55344720 | microRNA based prognostic biomarkers in pancreatic Cancer. |
| Q34920251 | microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma |
| Q38998609 | microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta |
| Q38366523 | p53, a translational regulator: contribution to its tumour-suppressor activity. |
Search more.